论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Liu Y, Yang J, Huo D, Fan H, Gao Y
Received 24 February 2018
Accepted for publication 21 May 2018
Published 23 July 2018 Volume 2018:10 Pages 2173—2181
DOI https://doi.org/10.2147/CMAR.S166437
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Dr Antonella D'Anneo
Purpose: The purpose of this study was to investigate the disclosure
incidence of cancer diagnosis to patients before chemotherapy, to survey the
attitudes of the patients and their families and related influencing factors
toward disclosure of cancer diagnosis, and to compare the anxiety and
depression levels between the disclosure and non-disclosure patients.
Participants
and methods: A prospective cohort
study was conducted at a tertiary hospital in China. A consecutive series of
patients who had been diagnosed with malignancy by pathology and their family
member were included in our study from March 2017 to December 2017. Patients’
situation, preferences, and their family members’ preferences were investigated
by a self-designed questionnaire following a semi-structured interview. The
Chinese version of HADS for anxiety and depression was used to test the
patients’ psychological distress. Binary logistic regression was used to
analyze the related influencing factors of patients’ disclosure of their
diagnosis.
Results: A total of 124 pairs of patients and their family members were
analyzed. Of the 124 patients, 47 (37.90%) patients knew about their cancer
diagnosis and 77 (62.10%) patients did not know about their cancer diagnosis
before chemotherapy. There were more patients than family members who wanted
the patients to be informed about the diagnosis of terminal illness (91.9% vs
53.2%, P <0.01). Binary logistic
regression analysis showed that patients with university education (odds ratio
[OR], 15.322; 95% confidence interval [CI], 1.781–131.781; P <0.05), patients having equal
or above average annual income (OR, 5.170; 95% CI, 1.842–14.514; P <0.01) were more likely
informed about cancer diagnosis before chemotherapy. Higher anxiety level was
found in diagnosis non-disclosure group (P <0.05) and no
significant difference in depression score between two groups (P >0.05).
Conclusion: More than half of the patients did not know their exact diagnosis
before chemotherapy in China. Educational level and economic status may be
influencing factors for the disclosure of cancer diagnosis. Patients and their
family members had different preferences toward diagnosis disclosure.
Keywords: cancer, diagnosis disclosure, China, patient, family member